Skip To Content

Study ID: WL Gore Viabahn ISR 14-04 Endoprosthesis FDA Mandated Post Approval Study

Title:

Post-Approval Study of the GORE VIABAHN Endoprosthesis for the Treatment of In-Stent Restenosis in the Superficial Femoral Artery (ISR 14-04)

Location:
Fargo Region
Principal Investigator:
Corey Teigen, MD
Disease:
Other
Stage:
IDE
Status:
Active - Open to Accrual

For more information, call or email Bismarck Clinical Research at (701) 323-5760, Fargo and Bemidji Clinical Research at (701) 234-5890, or Sioux Falls Clinical Research at (605) 328-1368.